BMJ  2005;331:713 (1 October), doi:10.1136/bmj.331.7519.713

News

FDA chief resigns without warning

Janice Hopkins Tanne

New York

The first 150 words of the full text of this article appear below.

After only two months as commissioner, but 30 years at the organisation, Lester Crawford, head of the Food and Drug Administration, abruptly resigned last Friday. He sent an email message to FDA staff members saying, "It is time, at the age of 67, to step aside."

President Bush immediately named Andrew von Eschenbach, director of the National Cancer Institute, as temporary commissioner. Dr von Eschenbach said he would continue to hold both jobs.

The New York Times this week reported an anonymous government official as claiming that Dr Crawford's resignation was related to the fact that he had not fully disclosed financial information during Senate hearings on his confirmation (Sep 24; Sect A: 1). Dr Crawford's wife, Catherine W Crawford, subsequently denied this on his behalf (New York Times, Sep 27; Sect A: 21).

Dr Crawford's resignation comes after a difficult year for the FDA, in which it . . . [Full text of this article]

-->
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Tanne, J. H. (2006). FDA appointment is stalled as revelations emerge over Plan B. BMJ 333: 317-317 [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ